To understand this difference in proliferation rates, we analyzed Ki-67 expression, a widely known marker of cell proliferation used to determine clinical aggressive behavior in related lymphomas such as mantle cell lymphoma [26,27]. This evidence concerns the gene MKI67 and lymphoma.